Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
Clinical trial NCT03712163 · COMPLETED
Trial details
- NCT number
- NCT03712163
- Sponsor
- Emergo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2019-02-18
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.